中國透雲(01332.HK):就生產微藻粉及相關產品建設發酵及相關設施簽訂協議
格隆匯5月14日丨中國透雲(01332.HK)公佈,於2020年5月14日,公司間接全資附屬山西透雲生物科技有限公司與承建商訂立該等協議,內容有關就生產微藻粉及相關產品建設發酵及相關設施。
根據日期為2020年2月21日的合作協議,區政府同意透過提供建設設施的相關土地使用權,支持建設萊茵衣藻及相關產品設施。於公告日期,公司已就正式申請土地使用權提交相關文件。於2020年4月9日,長治市潞城區自然資源局確認,建設佔地約12.44公頃的萊茵衣藻生產設施符合相關地區的整體土地用途規劃。
建設發酵及相關設施乃集團多元化發展萊茵衣藻、微藻粉及相關產品業務的第一步。預期公司將於2021年開始生產萊茵衣藻、微藻粉及相關產品。附屬公司目前已有12名僱員,包括經驗豐富且專長於處理萊茵衣藻、微藻粉發酵過程及生產管理的技術人員及工程師;及行政支援人員。
監於近年掀起一股健康食品熱潮,集團認為投資萊茵衣藻、微藻粉業務為本集團多元擴展其收入來源之良機。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.